Increasing Capacity
Capacity
There is a critical need to empower clinical researchers in Low- and Middle-Income Countries (LMICs) to lead the research response to epidemic infections. We offer a portfolio of research capacity building initiatives to support emerging clinical researchers in exchanging knowledge, gaining confidence in their research and leadership skills, developing local and regional research agendas, and ultimately increasing the international footprint of their institution both within ISARIC and further afield.
Collaboration is at the core of everything we do and our research capacity strengthening programmes focus on reaching out to, and working with a number of regional and international initiatives. Learn more about past and ongoing opportunities.
Clinical Research During Outbreaks (CREDO)
The CREDO training provides trainees with a set of skills to lead the research response in an outbreak, and strengthens the national capacities of LMICs to generate clinical evidence during outbreaks and facilitate networking and the sharing of resources.
Fellowship Programme
Latest news
Invitation to partner in the delivery and development of the ISARIC Clinical Characterisation Protocol
SUMMARY ISARIC is seeking two individuals, with the support of their institutions, to partner in the development and delivery of the ISARIC Clinical Characterisation Protocol (CCP). The ISARIC CCP is an observational study framework designed to rapidly characterise the clinical epidemiology and pathogenesis of epidemic prone infectious diseases to inform patient care and public health action. ISARIC provides template study documents, data management, database hosting, analytic tools, ...
The modern landscape of Ebola disease
In this series in The Lancet Infectious Diseases on the modern landscape of Ebola disease, we reflect on the 10-year anniversary of the west Africa (2014–16) epidemic and provide an overview of the progress made since then in improving clinical care for patients with Ebola disease. The first series paper focuses on advances in the understanding of the epidemiology and clinical manifestations of Ebola disease, along with developments in treatment and vaccines, care in special populations, ...
ISARIC launches Dengue Clinical Characterisation Protocol
In collaboration with clinicians and researchers from Asia and South America, ISARIC has launched the Clinical Characterisation Protocol for Dengue (CCP-Dengue). Dengue, a vector-borne, neglected tropical disease, is associated with substantial morbidity and mortality. The WHO estimates that 390 million dengue infections occur annually. 70% of this burden is in Asia. Recently, there have been massive dengue outbreaks around the world, with tragically high numbers of deaths in Bangladesh and